3Gazinsky E, Boege F. Urine screening with the UF- series analysers: the use of urine conductivity as a surrogate marker of urine osmolality and renal diuresis [J]. Sysmex J Int, 2002, 12(2) :76-79.
4Solberg HE. A guide to IFCC recommendations on reference values [ J ]. J Int Fed Clin Chem, 1993,5 (4) :162-165.
5Lord RC. Osmosis, osmometry, and osmoregulation [ J ]. Postgrad Med J, 1999,75 ( 880 ) :67-73.
6寇丽筠,陈宏础.临床基础检验学[M]卫生出版社,1997:101-102.
7Devuyst O. Dietary salt and renal stone disease [ J ]. Lancet, 1997,349 (9050) : 507.
8Chitalia VC, Kothari J, Wells [J, et al. Cost benefit analysis and prediction of 24-hour proteinuria from the spot urine pro- tein-creatinine ratio[J]. Clin Nephrol, 2001,55(6) :436 -447.
9Kidney Disease= Improving Global Outcomes (KDIGO) Glo mernlonephritis Work Group. KDIGO Clinical Practice Guide- line for Glomerulonephritis[J] Kidney inter, Suppl, 2012,2:139-274.
10Parikh CR, Gyamlani GG, Carvounis CP. Screening for mi croalbuminuria simplified by urine specific gravity[J]. Am J Nephrol,2002, 22(4):315-319.
